Cargando…

Virus–drug interactions—molecular insight into immunosuppression and HCV

Liver transplantation is an effective treatment for end-stage liver disease that is attributable to chronic HCV infection. However, long-term outcomes are compromised by universal virological recurrence in the graft. Reinfection that occurs after transplantation has increased resistance to current i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Qiuwei, Tilanus, Hugo W., Metselaar, Herold J., Janssen, Harry L. A., van der Laan, Luc J. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097508/ https://www.ncbi.nlm.nih.gov/pubmed/22508161 http://dx.doi.org/10.1038/nrgastro.2012.67

Ejemplares similares

Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing
por: Pan, Qiuwei, et al.
Publicado: (2009)

Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid
por: de Ruiter, Petra E, et al.
Publicado: (2018)

Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV
por: Wang, Wenshi, et al.
Publicado: (2016)

Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay
por: Tapirdamaz, Özlem, et al.
Publicado: (2010)

Physical fitness, fatigue, and quality of life after liver transplantation
por: van Ginneken, Berbke T. J., et al.
Publicado: (2007)

Letter to the Editor: High Mobility Group Box Protein 1 Release Is an Identified Driver of Inflammation in the Pathogenesis of Biliary Atresia
por: Shi, Shaojun, et al.
Publicado: (2021)

T Follicular Helper Cells As a New Target for Immunosuppressive Therapies
por: Yan, Lin, et al.
Publicado: (2017)

New drug interactions in HIV and HCV
por: Back, David
Publicado: (2012)

Characterization of Antigen-Presenting Cell Subsets in Human Liver-Draining Lymph Nodes
por: Boor, Patrick P. C., et al.
Publicado: (2019)

Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients
por: Lucafò, Marianna, et al.
Publicado: (2019)

Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma
por: Hernanda, Pratika Y., et al.
Publicado: (2013)

Recapitulating hepatitis E virus–host interactions and facilitating antiviral drug discovery in human liver–derived organoids
por: Li, Pengfei, et al.
Publicado: (2022)

Frequency of Potential Drug–Drug Interactions in the Changing Field of HCV Therapy
por: Schulte, Benjamin, et al.
Publicado: (2020)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

Pharmacokinetic Drug–Drug Interactions Between Immunosuppressant and Anti-Infective Agents: Antimetabolites and Corticosteroids
por: Van Matre, Edwart T., et al.
Publicado: (2018)

Dissecting the multifaceted impact of statin use on fatty liver disease: A multidimensional study
por: Ayada, Ibrahim, et al.
Publicado: (2022)

Assessment of human leukocyte antigen matching algorithm PIRCHE‐II on liver transplantation outcomes
por: Kok, Gautam, et al.
Publicado: (2022)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

Real clinical impact of drug–drug interactions of immunosuppressants in transplant patients
por: Gago‐Sánchez, Ana Isabel, et al.
Publicado: (2021)

Immunosuppressive Drugs
por: Hussain, Yaseen, et al.
Publicado: (2022)

Insight into the drug resistance mechanisms of GS-9669 caused by mutations of HCV NS5B polymerase via molecular simulation
por: Han, Di, et al.
Publicado: (2021)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

New insights into leishmaniasis in the immunosuppressed
por: Akuffo, Hannah, et al.
Publicado: (2018)

Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development
por: Chen, Sunrui, et al.
Publicado: (2020)

Molecular and spatial epidemiology of HCV among people who inject drugs in Boston, Massachusetts
por: Stopka, Thomas J., et al.
Publicado: (2022)

Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Cellular and Molecular Mechanisms of Mesenchymal Stem Cell Actions
por: Christ, Bruno, et al.
Publicado: (2017)

RNA editing blood biomarkers for predicting mood alterations in HCV patients
por: Salvetat, N., et al.
Publicado: (2019)

HCV Kinetic Models and Their Implications in Drug Development
por: Nguyen, THT, et al.
Publicado: (2015)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Immunosuppressive drugs and fertility
por: Leroy, Clara, et al.
Publicado: (2015)

An 'elaborated' pseudoknot is required for high frequency frameshifting during translation of HCV 229E polymerase mRNA.
por: Herold, J, et al.
Publicado: (1993)

Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly population
por: Alferink, Louise J. M., et al.
Publicado: (2020)

Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study
por: Weersink, Rianne A., et al.
Publicado: (2018)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study
por: Hullegie, Sebastiaan J., et al.
Publicado: (2017)

Drug-Drug Interactions Among Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Medications
por: Kaur, Kirpal, et al.
Publicado: (2015)

Human Bone Marrow Stromal Cells Lose Immunosuppressive and Anti-inflammatory Properties upon Oncogenic Transformation
por: Rodriguez, Rene, et al.
Publicado: (2014)

Immunosuppressive drugs : developments in anti-rejection therapy
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_brfmqh2pbv040225lsp9udn33o